RASBURICASE powder and solvent for concentrate for solution for infusion (Fasturtec®▼) for severe, refractory, tophaceous gout - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

RASBURICASE powder and solvent for concentrate for solution for infusion (Fasturtec®▼) for severe, refractory, tophaceous gout

Last Updated: 28 June 2017

Body System: Musculoskeletal system

Black

The Pan Mersey Area Prescribing Committee does not recommend the prescribing of Rasburicase powder and solvent for concentrate for solution for infusion (Fasturtec®▼) for the “off label” treatment of severe, refractory, tophaceous gout resistant to xanthine oxidase inhibitors (allopurinol & febuxostat) and uricosuric agents (benzbromarone) or for whom these drugs are contraindicated.